SANOFI VACCINES US INC. - ACQUISITION OF EGG-BASED INFLUENZA MASTER AND WORKING SEED LOTS DERIVED FROM A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345-001/2021 (H5N1) CANDIDATE VACCINE VIRUS AND FILL-FINISH OF ANY EXISTING EGG-BASED A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345/2021
Key Details
Description
ACQUISITION OF EGG-BASED INFLUENZA MASTER AND WORKING SEED LOTS DERIVED FROM A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345-001/2021 (H5N1) CANDIDATE VACCINE VIRUS AND FILL-FINISH OF ANY EXISTING EGG-BASED A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345/2021
Context & Analysis
On Dec 17, 2025, Department of Health and Human Services obligated $680,955 to SANOFI VACCINES US INC. for acquisition of egg-based influenza master and working seed lots derived from a/american wigeon/south carolina/22-000345-001/2021 (h5n1) candidate vaccine virus and fill-finish of any existing egg-base…. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in SWIFTWATER, PA. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.